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n INTRODUCTION 
In order for antimicrobial therapy to be effec-tive, it is usually necessary to remove implanted 
devices. The formation of adherent, multilayered 
bacterial biofilms is the most important factor for 
the pathogenesis of medical device-related staphy-
lococcal infections. Therefore, it is imperative that 
we develop a better understanding of the func-
tional factors involved in biofilm formation, the 
mechanisms that regulate their expression, and 
the interaction between those potential virulence 
factors and the host in device-related infection [1, 
2]. Important developments in the last few years 
may ultimately lead to judicious new approaches 
to prevention, diagnosis and treatment. The only 
sign of bone infection in non-diabetic and im-
mune-competent patients may be a local symptom 
such as skin ulceration from a bony fistula. Some 
recent studies have shown that treatment with a 
combination of vasodilator prostaglandins, such 
as prostaglandin E1 (PGE1) and prostaglandin E2 
(PGE2), and antibiotics can lead to a rapid recovery 
from osteomyelitis, without the need for orthope-
dic surgery [3, 4]. The prostaglandins appear to 
reduce biofilm formation and chronicization of 
the infection, and stimulate a rapid and effective 
clearance of the infecting microorganism [5]. Here 
we report a case of recovery from Staphylococcus 
aureus osteomyelitis after management with anti-
biotics, anti-thrombotics and PGE1 vasodilator in 
a patient with previous tibial plateau fracture re-
paired with internal fixation devices.
n CASE REPORT 
In December 2013, a 47-year-old patient with 
osteomyelitis and chronic ulcer on the proximal 
third of his left leg was examined at the Ortho-
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pedic Unit of “Orestano Clinic” in Palermo, Italy.
No comorbidities or risk factors were reported 
in his past medical history. Two years before, the 
patient had had open reduction internal fixation 
(ORIF) surgery in a different hospital to repair 
both complex tibial plateau fractures (Schatzker 
type V; complex Schatzker type V injury with 
shaft dissociation and lateral articular surface im-
paction) in his left leg. No acute vascular lesions 
or severely compromised soft tissues were report-
ed. One year later, the patient underwent another 
operation to remove the fixators as he was expe-
riencing tibial pain and pain over the locking bolt 
sites, which was compromising work-related and 
leisure activities. Laboratory and microbiologi-
cal examinations of intraoperative samples car-
ried out at that time had excluded any bacterial 
colonization/infection. The patient reported an 
improvement in pain, although mild functional 
limitations persisted, mainly regarding weight-
bearing ability while walking. Five months be-
fore we examined him, he had noticed the onset 
of local phlogosis with serous and subsequently 
purulent discharge at the site where the fixators 
had been removed and which was not healing 
correctly. Skin biopsy specimens of the leg ulcer 
were positive for methicillin-susceptible Staphylo-
coccus aureus (MSSA). Identification (ID) and an-
timicrobial susceptibility testing (AST) were rou-
tinely performed using a microdilution method 
(BD Phoenix™ Automated Microbiology System, 
Sparks, MD, US). The minimum inhibitory con-
centration of the MSSA strain isolated was as fol-
lows: oxacillin <0.5 mg/L; rifampin <0.5 mg/L; 
clindamycin <0.5 mg/L; levofloxacin <1 mg/L; 
vancomycin <1 mg/L; teicoplanin <0.5 mg/L; 
trimethoprim/ sulfamethoxazole <0.5/9.5 mg/L; 
gentamicin <0.5 mg/L; imipenem/meropemen 
<1 mg/L; erythromycin >1 mg/L; tetracycline 
>1 mg/L. The strain showed resistance to tetra-
cycline and macrolides. Results were interpreted 
using the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) clinical break-
points [6]. A whole-body bone scintigraphy with 
99mTc radioleukocytes (99mTc-WBC) and planar 
focal bone scan of the knees was performed at the 
Arnas-Civico Hospital, Palermo Italy. Two tracer 
accumulations were observed, one in the region of 
the tibial plateau and the other situated more cen-
trally (Figure 1). Following the patient’s wishes, 
antibiotics were administered orally, as follows: 
rifampicin 600 mg q 24 h plus trimethoprim-sul-
famethoxazole (160 mg-800 mg twice a day).
Three weeks later, the patient was admitted to 
the Vascular Surgical Unit of “Orestano Clinic”, 
as there had been no improvement in his clinical 
condition.
When he presented to us, he had been experienc-
ing severe walking difficulties and had extensive 
ulceration on his left leg (Figure 2). Vital signs on 
admission were as follows: temperature 38.5°C, 
blood pressure 120/75 mmHg, pulse 95 beats/
min, respiratory rate 22 breaths/min, and oxygen 
saturation 99% on room air. Relevant laboratory 
values on admission were as follows: leukocy-
tosis with 13,700 leukocytes with prevalence of 
segmented elements (83%) and C-reactive protein 
(CRP) 21 mg/L (normal range <0.8 mg/dl).
Figure 1 - “Whole body” biodistribution scintigraphy 
with intravenously administered radiolabeled auto-
logous leukocytes and planar focal comparative and 
serial imaging of the knees at 3 and 24 hours showed 
two roundish, well-defined tracer accumulations of 
leukocytic phlogosis, one in the region of the lateral 
tibial plateau and the other more centrally located. 
They tend to increase in intensity over time (at 24 
hours) and localize in a more evident manner.
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CT scan of the leg showed a high intensity area 
around the left proximal tibia. Blood culture iden-
tified MSSA with the same susceptibility profile 
as MSSA isolated from the skin biopsy. Conse-
quently, the patient attended the “Orestano Clin-
ic” Day Hospital facility to undergo the following 
4-day therapeutic cycle: PGE1 (alprostadil 60 mg/
day IV diluted with 250 cc of physiological solu-
tion in 3 hours, once a day) combined with nad-
roparin calcium (3800UI/0,4 ml, SC once a day) 
and gentamicin (6 mg/kg IV every 24 hours). 
This was subsequently followed by orally ad-
ministered outpatient treatment with aminaftone 
(2-hydroxy-3-methyl- 1,4 naphthohydroquinone-
2-p-aminobenzoate) 75mg/day plus propionyl 
L carnitine 1 g/day plus sulodexide 50 mg/day 
plus levofloxacin 750 mg one daily. The patient 
received this combination therapy for one month. 
During the treatment, outpatient vascular sur-
gery evaluations showed an improvement in lo-
cal symptoms and rapid re-epithelialization of the 
ulcer. We therefore recommended a second 4-day 
cycle of the intravenous treatment administered at 
the Day Hospital facility. At the time of discharge, 
the patient’s painful symptoms had completely 
resolved and the ulcer had cicatrized (Figure 3); 
recovery from osteomyelitis was confirmed with 
a repeat scintigraphy.
n DISCUSSION 
Despite the development of various new methods 
of fracture reduction, implants for fracture fixa-
tion and better soft tissue handling techniques, 
decisions regarding the optimal treatment of 
Schatzker type V and VI tibial plateau fractures are 
controversial and challenging. Most patients have 
significant residual dysfunction after the comple-
tion of treatment [1]. Postoperative skin infections 
and osteomyelitis are prominently described in 
even the most recent, sophisticated protocols of 
international Orthopedic Trauma Societies [7]. 
For this reason, the authors do not attempt to dis-
cuss here the best surgical options, as this requires 
a specialized and multidisciplinary approach. To-
day, more than ever before, this type of orthope-
dic surgery takes a personalized approach, tak-
ing into account the characteristics of the initial 
trauma, the patient’s risk factors and follow-up 
rehabilitation. Instead, we propose a new proto-
col for the management of infectious complica-
tions. After close examination of the literature, we 
maintain that this is the first clinical case of rapid 
recovery from osteomyelitis with ulceration due 
to bone fistulization in an immune-competent pa-
tient with no risk factors (e.g., diabetes), following 
a treatment protocol for potential post-fracture in-
Figure 2 - Patient’s ulcerative lesion on admission.
Figure 3 - Patient’s ulcerative lesion after treatment.
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fection complications that included PGE1. Recent 
studies have shown that prostaglandin-E and -I 
derivatives are potent stimulators of adenylate 
cyclase enzymes, producing cyclic adenosine mo-
nophosphate (cAMP) and inhibiting thrombocyte 
functions. These molecules induce vasorelaxation 
via direct effects on vascular smooth muscle, and 
by reducing oxygen consumption and superoxide 
anion production in injured organs [3-5].
Our case appears to corroborate the recent ob-
servations published by Lovati et al. [3, 4] which 
suggest that a combination of antibiotics and va-
sodilators may prevent bone infections in animal 
models. PGE1 administration was found to sig-
nificantly decrease the incidence of SSI in patients 
with spinal metastasis who underwent preop-
erative irradiation [8]. In our case, treatment was 
adapted to the wishes of the patient who refused 
intravenous antibiotics, therefore we prescribed 
combination treatment with rifampicin which ap-
pears to have a better outcome in oral therapy.
Nevertheless, it was only when we combined an-
tibiotic therapy - and it should be noted that this 
involved a single antibiotic - with vascular-active 
substances that we saw a rapid improvement in 
the lesion and in clinical symptoms. Recently, 
evidence of their role in no-reflow phenomenon 
to hepatic injury after ischemia- reperfusion in 
transplanted patients has been reported [9].
It is possible that similar changes can occur after 
PGE1 administration in the bone vessels, where 
alprostadil associated with nadroparin calcium 
may contribute to intraosseous hyperperfusion 
and block toxic osteonecrosis associated with 
osteomyelitis. Moreover, sulodexide (SDX), a 
sulfated polysaccharide complex extracted from 
porcine intestinal mucosa, which is a blend of 
two glycosaminoglycan (GAG) entities, namely a 
fast-moving heparin (HP) fraction and a derma-
tan sulfate (DS; 20%) component, has been recom-
mended for the treatment of vascular disease [10]. 
Findings on animal models suggest that a combi-
nation of antibiotics and vasodilators can prevent 
bone infections. On the basis of this case report 
and other research on organ transplants and ani-
mals, the authors suggest that PGE1 has a favor-
able role in the evolution of bone infections. In 
conclusion, the case reported herein suggests that 
in the event of an accident at work, the protocol 
we used to treat osteomyelitis with cutaneous 
fistulization could reduce the healing time be-
tween the primary lesion and osteomyelitis com-
plication. Whether these positive results will be 
confirmed later by other clinical trials could be a 
benefit for patients, with a significant improve-
ment in quality of life and functional status and 
reduction in direct and indirect costs, in terms of 
a quicker recovery and return to work, fewer per-
manent after-effects and a lighter temporal and 
economic burden on the National Health Service.
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Prostaglandins appear to reduce biofilm formation and 
chronicization of infections, and stimulate a rapid and 
effective clearance of infecting micro-organisms. We 
report a case of recovery from methicillin-susceptible 
Staphylococcus aureus (MSSA) osteomyelitis after multi-
disciplinary management with antibiotics, anti-throm-
botics and prostaglandin E1 (PGE1) vasodilator, in a pa-
tient with tibial plateau fracture repaired with internal 
fixation devices. A 47-year-old HIV-negative male with 
chronic ulcer on the proximal third of the left leg was 
admitted to the Orthopaedic Unit of the Orestano Clinic 
in Palermo, Italy, for suspected osteomyelitis. A biopsy 
of the skin ulcer and blood cultures were performed and 
resulted positive for MSSA. Labelled leukocyte scintig-
SUMMARY
raphy confirmed osteomyelitis. No clinical improve-
ment was observed after combined antibiotic treatment 
with rifampicin plus trimethoprim-sulfamethoxazole. 
The patient underwent a 4-day therapeutic cycle: PGE1 
(alprostadil 60 mg/day IV) combined with nadroparin 
calcium plus gentamicin, followed by treatment with 
aminaftone plus sulodexide plus levofloxacin. At dis-
charge, the patient’s painful symptoms had completely 
resolved and the ulcer had cicatrized; recovery from 
osteomyelitis was confirmed by scintigraphy. This treat-
ment protocol including PGE1 may result in a significant 
improvement in quality of life and functional status of 
patients with a reduction in direct and indirect costs and 
economic benefit for the National Health Service.
73Leg ulcer and osteomyelitis due to methicillin-susceptible Staphylococcus aureus infection
Le prostaglandine sembrano ridurre la formazione di 
biofilm e la cronicizzazione delle infezioni, e stimola-
re una rapida ed efficace guarigione delle infezioni da 
parte di microrganismi patogeni. Al fine di riportare 
l’attenzione sulla rilevanza clinica di un trattamento 
multidisciplinare, descriviamo un caso di trattamento 
di osteomielite da Staphylococcus aureus meticillino-
sensibile (MSSA), trattata con antibiotici, antitrombo-
tici e un farmaco vasodilatatore, la prostaglandina E1 
(PGE1), verificatosi in un paziente sottoposto a inter-
vento chirurgico per frattura del piatto tibiale.
Nel dicembre 2013 un paziente di 47 anni con osteomie-
lite cronica e ulcera sul terzo prossimale della gamba 
sinistra, è stato ricoverato presso l’Unità di Ortopedia 
della “Clinica Orestano” di Palermo, Italia. Sono stati 
eseguiti una biopsia dell’ulcera ed esame colturale che 
risultò positivo, al pari delle emocolture, per MSSA. La 
RIASSUNTO
scintigrafia ha confermato la diagnosi di osteomielite. 
Nessun miglioramento clinico è stato osservato dopo il 
trattamento antibiotico combinato con rifampicina più 
trimetoprim-sulfametossazolo. 
Il paziente è stato sottoposto a 4 giorni di ciclo tera-
peutico con PGE1 (alprostadil 60 mg/die IV) in com-
binazione con nadroparina calcio più gentamicina, 
seguita da trattamento con aminaftone più sulodexide 
più levofloxacina. Alla dimissione, la sintomatologia 
dolorosa era del tutto risolta e l’ulcera cicatrizzata; la 
guarigione dell’osteomielite è stata confermata me-
diante scintigrafia.
Il protocollo di trattamento che includeva PGE1, può 
indurre un significativo miglioramento della qualità 
della vita e dello stato funzionale dei pazienti con ridu-
zione dei costi diretti e indiretti e conseguenti benefici 
economici per il Servizio Sanitario Nazionale.
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